LevoCept IUD Study

 

This study is being conducted at the University of Pennsylvania to research a levonorgestrel-releasing hormonal contraceptive that is placed in the uterus and is intended to prevent pregnancy, known as LevoCept. This device is experimental and is being developed as a possible method of long-acting reversible contraception.

 

“Experimental” means that LevoCept has not yet been approved by the Food and Drug Administration (FDA) for sale in the United States. 

The study will investigate the safety and effectiveness of LevoCept in preventing pregnancy. We will also be looking at any effects on menstrual cycle periods and bleeding, and assess any side effects. Study participation involves 6 visits over approximately one year, as well as monthly telephone calls and completion of a daily electronic chart to record menstrual bleeding, sexual activity, and any side effects. 

Qualified participants:

  • Healthy women ages 18 - 35

  • Have regular menstrual periods

  • Willing to use the study device as their only method of birth control during the study

  • Not seeking pregnancy for at least 1 year

  • Sexually active with a regular male partner

 

Qualified participants will receive:

  • Medical exams

  • $50-75 per completed study visit (a maximum of $1,195 for the first year)

  • LevoCept IUD

If you are interested in participating in this study, complete the online pre-screener here or contact Brittany Lang at 215-662-4725 or brittany.lang@uphs.upenn.edu for more information.

© 2017 by Penn Medicine Women's Health Clinical Research Center

University of Pennsylvania, Philadelphia PA

(215) 662-7727